Pfizer secures $10 billion Metsera deal after Novo Nordisk withdraws
Pfizer’s $10 billion acquisition of Metsera marks a major victory for the U.S. pharmaceutical giant, strengthening its position in the
Read More
Factual Version of a Story
weight-loss drug development